 preval tardiv dyskinesia neuroleptic-tr diabet control studi control studi preval tardiv dyskinesia neuroleptic-tr diabet preval tardiv dyskinesia group nondiabet neuroleptic-tr control age sex psychiatr diagnosi dose durat neurolept treatment member group movement disord rater standard rate scale blind diagnos treatment neuroleptic-tr diabet preval sever tardiv dyskinesia differ group possibl risk factor tardiv dyskinesia parkinson anticholinerg drug treatment cognit function data mellitu risk factor tardiv dyskinesia